期刊
JOURNAL OF WOMENS HEALTH
卷 30, 期 5, 页码 634-641出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jwh.2020.8828
关键词
osteoarthritis; arthritis; chronic pain; sex as a biological variable
类别
资金
- Pfizer, Inc.
- Eli Lilly and Company
- Teva Pharmaceuticals
- Regeneron Pharmaceuticals
OA affects over 300 million individuals globally, with higher prevalence in women than in men. Women tend to have more severe disease and disability. The Society for Women's Health Research convened a roundtable to review the current state of the science on OA and identify knowledge gaps related to sex and gender, prioritizing areas of need for further attention in research, diagnosis, care, and education.
Osteoarthritis (OA) affects more than 300 million individuals globally, with higher prevalence in women than in men. In addition, OA affects women and men differently, with women demonstrating both increased disease severity and disability. The Society for Women's Health Research convened an interdisciplinary group of expert researchers and clinicians for a roundtable meeting to review the current state of the science on OA and to identify knowledge gaps in the scientific literature, especially as they relate to the topics of sex and gender. The current review summarizes discussions from the roundtable and prioritizes areas of need that warrant further attention in OA research, diagnosis, care, and education. Improvements in basic and clinical research, clinical practice, patient education, and policy are needed to allow for better understanding as to the pathogenesis of sex- and gender-related disparities in OA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据